drugset / Trial / NCT00371306

Comparison of Glucovance to Insulin for Diabetes During Pregnancy

NCT00371306

Unknown 200 enrolled Regional Obstetrical Consultants
RandomizedSingle-groupSingle-blindTreatment

Summary

Pregnant women with gestational or Type 2 diabetes who require medication are placed in one of two groups: Insulin injections or Glucovance (oral administration). Blood glucose is checked 5 times per day, and medication adjusted by perinatologist according to glucose levels. The hypothesis is that patients will have similar or improved blood glucose control on an oral agent as compared to control on insulin.

Timeline

Start
2002-09
Primary completion
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Glyburide Small molecule 1.25 mg Oral
Subject Glyburide Small molecule 5 mg Oral
Subject Insulin Protein / enzyme biologic 1 iu/kg Other
Subject Metformin Small molecule 250 mg Oral
Subject Metformin Small molecule 500 mg Oral